www.fdanews.com/articles/146023-sunshine-heart-rsquo-s-david-rosa-ldquo-patients-don-rsquo-t-like-being-tethered-to-a-device-rdquo
Sunshine Heart’s David Rosa: “Patients Don’t Like Being Tethered to a Device”
May 1, 2012
“In the U.S., for Class III heart failure there are about 1.5 million patients,” Sunshine Heart CEO David Rosa said. “That’s about 7 times the Class IV market, which is traditionally where LVADs participate.”
Mass Device
Mass Device